top of page

Expanding the reach of antibody therapeutics​

Determined to revolutionize the reach of cancer treatment by developing potent and precise therapies that can target the entire universe of cancer antigens.

Why Crossbow

antibody-2.png

We aim to cure cancer. Our team is urgently working to create an arsenal of therapeutics that expands the reach and impact of antibodies used to treat cancer.​

 ​​

We chose the name Crossbow because our next-generation therapies embody the precision and power of a crossbow. With unparalleled accuracy and potency, our T-Bolt   molecules strike tumor cells like a crossbow shoots bolts at its target.​​

 ​

Join us on our bold quest to broaden the benefits of immunotherapy and improve the lives of people living with cancer.

TM

Science

What we do

slide 3.png

Selecting from the expanding universe of cancer antigens

We identify, validate and prioritize the most promising cancer antigens for our T-Cell Receptor Mimetic (TCRm) discovery efforts​.

Who we are

A team of international, collaborative and experienced inventors, drug developers and company builders. We value scientific excellence, passion, integrity, innovation, transparency, respect and accountability. We embrace problems deemed impossible to solve.

heashots_updated3.png
174857.png
Briggs Morrison,
M.D.

Chief Executive Officer, President

Group 8.png
heashots_updated10.png
174857.png
Michael
Princiotta, Ph.D.

Senior Vice President, Head of Biology

Group 8.png
BenLee-headshot.jpg
174857.png
Benjamin Lee,
M.D., Ph.D.

Senior Vice President, Head of Translational Medicine 

 

Group 8.png
heashots_updated5.png
174857.png
Dmitri
Wiederschain, Ph.D.

Chief Scientific Officer

Group 8.png
heashots_updated2.png
174857.png
Amanda Mak,
Ph.D.

Vice President, Head of Antibody Discovery, Protein Engineering, Process Development

Group 8.png
Alex Nolte_edited.png
174857.png
Alexander Nolte,
C.P.A.

Senior Vice President, Head of Finance

Group 8.png
heashots_updated6.png
174857.png
Geraldine Paulus, Ph.D.

Co-founder, Vice President, Head of Corporate Development and Operations

Group 8.png
heashots_updated4.png
174857.png
Tao Wang,
M.S.

Vice President, Head of Product Discovery, Boston Site Head

Group 8.png
heashots_updated8.2.png
174857.png
Jeanette
Kohlbrenner, M.B.A.

Consulting Head of Human Resources

 

Group 8.png
Team

Join us

Working at Crossbow

Our people are the key to everything we accomplish. We offer outstanding programs to support your career and personal life:

Hit your next career target at Crossbow!

Corporate Controller

View full job description

Competitive
Compensation

Professional Development

Associate Director/Director, Program Management

View full job description

Excellent Benefits

Generous Time Off

Commuting Benefits

News & Media

Keep up to date with everything happening at Crossbow.

October 11, 2023

Crossbow Therapeutics Announces Formation of its Scientific Advisory Board 

Read More

July 11, 2023

​Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance  
a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer

Read More

Contact Us

Thanks for submitting!

bottom of page